Metabolic syndrome (MetS) is a set of cardiovascular risk factors which severely increases
the risk of type II diabetes, renal disease and cardiovascular disease. Over the last decades, …

… The term metabolic syndrome refers to a virulent and lethal group of atherosclerotic risk
factors, including dyslipidemia, insulin resistance, obesity, and hypertension. This …

… metabolism, central obesity, elevated blood pressure, and dyslipidemia is identified as metabolic
syndrome … Metabolic syndrome increases the risk of developing cardiovascular disease …

… Metabolic syndrome (MS) is a complex of interrelated and modifiable risk factors for the …
19) Grundy SM Drug therapy of the metabolic syndrome: minimizing the emerging crisis in …

… of metabolic syndrome (MS). Hop flavonoids, particularly xanthohumol (XN), are substances
with hypoglycemic, antihyperlipidemic, and antiobesity activities. Iso-α-acids (IAA) and …

… Metabolic syndrome (MS) is a complex of interrelated and modifiable risk factors for the
development of cardiovascular diseases (CVD) and type 2 diabetes mellitus (diabetes) (as …

… prevention and treatment of obesity and other risk factors associated with the metabolic
syndrome… effectiveness in risk reduction of the metabolic syndrome and obesity-related diseases. …

… , the initial therapeutic approach to the metabolic syndrome should focus on … therapeutic
lifestyle change as the nonpharmacologic approach to management of the metabolic syndrome…

… Thus, at present it is reasonable to add fenofibrate to statin therapy in high-risk patients with
metabolic syndrome; nonetheless, RCT evidence of benefit is limited. Finally, in patients with …

… The fi rst stage in its successful preventive management is identification of the population at
… developing metabolic syndrome. The therapeutic approach to metabolic syndrome consists …